EVH
Evolent Health·NYSE
--
--(--)
--
--(--)
3.80 / 10
Netural
Sentiment is neutral (3.8) but fund flow is good (7.6), with overall and extra‑large inflows positive while small/medium/large are negative. Analysts are 75% Strong Buy, yet all have 0% historical win rates and price has fallen 26.8%, reflecting pessimistic market expectations.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
75%
Buy
13%
Hold
0%
Sell
0%
Strong Sell
0%
Daniel GrosslightStrong Buy
Date2026-02-26
InstitutionCitigroup
Times predicted3
Historical Win Rate0.0%
David LarsenStrong Buy
Jailendra SinghStrong Buy
Kevin CaliendoStrong Buy
Matthew GillmorStrong Buy
What is the analyst consensus for EVH?
- EVH holds a Bearish analyst rating, with 75% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.80/10 (Netural).
